Allogene Therapeutics (ALLO) Tax Rate (2018 - 2019)
Allogene Therapeutics (ALLO) posted Tax Rate of 0.21% for Q4 2019, down 55.68% sequentially from 0.48% in Q2 2019, and down 17.0% YoY from 0.26% in Q4 2018.
Allogene Therapeutics (ALLO) Tax Rate (2018 - 2019) Analysis & Trends
Allogene Therapeutics has reported Tax Rate for 2 years, with the latest figure at 0.21% in Q4 2019.
- Quarterly Tax Rate fell 17.0% year-over-year to 0.21% in Q4 2019, while the trailing twelve-month figure through Sep 2020 was 0.05% (down 18.0% YoY) and the FY2024 annual result came in at 0.17%, changed N/A from the prior year.
- Tax Rate fell to 0.21% in Q4 2019 per ALLO's latest filing, from 0.48% in the prior quarter.
- Over five years, Tax Rate peaked at 0.48% in Q2 2019 and troughed at 0.16% in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | Allogene Therapeutics | 707.96 Mn | 707.96 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 0.21% |
| Dec 31, 2019 | 0.21% |
| Dec 31, 2019 | 0.21% |
| Jun 30, 2019 | 0.48% |
| Jun 30, 2019 | 0.48% |
| Jun 30, 2019 | 0.48% |
| Mar 31, 2019 | 0.16% |
| Mar 31, 2019 | 0.16% |
| Mar 31, 2019 | 0.16% |
| Dec 31, 2018 | 0.38% |
| Dec 31, 2018 | 0.38% |
| Dec 31, 2018 | 0.38% |